Get the Stockscreener App
1.61
3.12%
0.01
Intercure Ltd stock is traded at $1.61, with a volume of 10,935.
It is up +3.12% in the last 24 hours and up +5.10% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$1.60
Open:
$1.615
24h Volume:
10,935
Relative Volume:
0.17
Market Cap:
$87.22M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
12.21
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
+3.77%
1M Performance:
+5.10%
6M Performance:
+33.50%
1Y Performance:
-9.84%
1-Day Range:
$1.615
$1.65
1-Week Range:
$1.50
$1.69
52-Week Range:
$1.17
$1.82
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.65 | 87.22M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
142.35 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.74 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.0409 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.10 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.94 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
Analyzing net buyer seller activity in InterCure Ltd.Market Growth Review & Verified Technical Trade Signals - newser.com
Momentum divergence signals in InterCure Ltd. chart2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Trend analysis for InterCure Ltd. this week2025 Top Decliners & Safe Swing Trade Setups - newser.com
Short interest data insights for InterCure Ltd.Market Trend Report & Growth-Oriented Investment Plans - newser.com
How to build a custom watchlist for InterCure Ltd.2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Long term hold vs stop loss in InterCure Ltd.Quarterly Portfolio Summary & Intraday High Probability Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for InterCure (NASDAQ:INCR) - MarketBeat
What MACD signals say about InterCure Ltd.Trade Signal Summary & Weekly High Return Stock Forecasts - newser.com
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewswire
Chart overlay techniques for tracking InterCure Ltd.Analyst Upgrade & Weekly High Conviction Ideas - newser.com
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow - MarketScreener
Intercure Reports First Half 2025 Results With NIS 130 Million In Revenue And Positive Operating Cash Flow - TradingView
InterCure Announces Strong First Half 2025 Results Amid Strategic Expansion - TipRanks
Using Bollinger Bands to evaluate InterCure Ltd.July 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
What drives InterCure Ltd stock priceTrendline Breakouts & Build Wealth With Strategy - earlytimes.in
What to expect from InterCure Ltd. in the next 30 daysShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Is InterCure Ltd. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Risk vs reward if holding onto InterCure Ltd.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Is InterCure Ltd. still worth holding after the dip2025 Volume Leaders & Real-Time Volume Analysis - newser.com
InterCure (NASDAQ:INCR) Shares Up 0.6% – Time to Buy? - Defense World
Can InterCure Ltd. rally from current levels2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
Why InterCure Ltd. stock is favored by pension funds2025 AllTime Highs & Safe Entry Point Alerts - newser.com
What high frequency data says about InterCure Ltd.Portfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
Will InterCure Ltd. bounce back from current supportWeekly Trend Recap & Technical Analysis for Trade Confirmation - newser.com
InterCure to acquire US-focused cultivator ‘ISHI’ as rescheduling optimism lingers - Mugglehead Magazine
Acquisitions give Israeli company access to US cannabis market - MMJDaily
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):